WallStreetZenWallStreetZen

NASDAQ: CSTL
Castle Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CSTL

Based on 5 analysts offering 12 month price targets for Castle Biosciences Inc

Min Forecast
$40.00+95.5%
Avg Forecast
$44.40+117.01%
Max Forecast
$52.00+154.15%

Should I buy or sell CSTL stock?

Based on 5 analysts offering ratings for Castle Biosciences Inc.

Strong Buy
Strong Buy
4 analysts 80%
Buy
1 analysts 20%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CSTL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CSTL as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their CSTL stock forecasts and price targets.

CSTL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-13
lockedlocked$00.00+00.00%2026-05-07
lockedlocked$00.00+00.00%2026-04-20
lockedlocked$00.00+00.00%2026-01-26Find Out Why
lockedlocked$00.00+00.00%2026-01-12

1 of 1

Forecast return on equity

Is CSTL forecast to generate an efficient return?

Company
2.15%
Industry
-86.05%
Market
175.71%
CSTL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CSTL forecast to generate an efficient return on assets?

Company
1.81%
Industry
14.94%
CSTL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CSTL earnings per share forecast

What is CSTL's earnings per share in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
-$1.48
Avg 2 year Forecast
-$0.84
Avg 3 year Forecast
-$0.51

CSTL revenue forecast

What is CSTL's revenue in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$359.5M+5.75%
Avg 2 year Forecast
$400.8M+17.9%
Avg 3 year Forecast
$443.2M+30.4%
CSTL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CSTL revenue growth forecast

How is CSTL forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
9.23%
Industry
8.07%
Market
13.84%
CSTL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CSTL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CSTL vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
CSTL$20.46$44.40+117.01%Strong Buy
ACRS$4.34$11.80+171.89%Strong Buy
FLGT$17.99$15.00-16.62%Hold
MYGN$4.25$5.83+37.25%Hold
PRE$20.51$29.50+43.83%Strong Buy
View Top Diagnostic & Research Stocks

Castle Biosciences Stock Forecast FAQ

Is Castle Biosciences Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: CSTL) stock is to Strong Buy CSTL stock.

Out of 5 analysts, 4 (80%) are recommending CSTL as a Strong Buy, 1 (20%) are recommending CSTL as a Buy, 0 (0%) are recommending CSTL as a Hold, 0 (0%) are recommending CSTL as a Sell, and 0 (0%) are recommending CSTL as a Strong Sell.

If you're new to stock investing, here's how to buy Castle Biosciences stock.

What is CSTL's earnings growth forecast for 2026-2028?

(NASDAQ: CSTL) Castle Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 18.53%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.54%.

Castle Biosciences's earnings in 2026 is -$12,832,000.On average, 10 Wall Street analysts forecast CSTL's earnings for 2026 to be -$44,936,857, with the lowest CSTL earnings forecast at -$51,718,634, and the highest CSTL earnings forecast at -$33,120,308. On average, 10 Wall Street analysts forecast CSTL's earnings for 2027 to be -$25,501,424, with the lowest CSTL earnings forecast at -$31,803,988, and the highest CSTL earnings forecast at -$11,783,186.

In 2028, CSTL is forecast to generate -$15,468,276 in earnings, with the lowest earnings forecast at -$35,965,257 and the highest earnings forecast at $2,866,180.

What is CSTL's revenue growth forecast for 2026-2028?

(NASDAQ: CSTL) Castle Biosciences's forecast annual revenue growth rate of 9.23% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.84%.

Castle Biosciences's revenue in 2026 is $339,920,000.On average, 10 Wall Street analysts forecast CSTL's revenue for 2026 to be $10,902,101,246, with the lowest CSTL revenue forecast at $10,409,239,526, and the highest CSTL revenue forecast at $11,299,120,318. On average, 10 Wall Street analysts forecast CSTL's revenue for 2027 to be $12,155,031,564, with the lowest CSTL revenue forecast at $11,422,563,223, and the highest CSTL revenue forecast at $12,913,886,963.

In 2028, CSTL is forecast to generate $13,443,447,924 in revenue, with the lowest revenue forecast at $12,063,435,108 and the highest revenue forecast at $14,605,085,086.

What is CSTL's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: CSTL) forecast ROA is 1.81%, which is lower than the forecast US Diagnostics & Research industry average of 14.94%.

What is CSTL's Price Target?

According to 5 Wall Street analysts that have issued a 1 year CSTL price target, the average CSTL price target is $44.40, with the highest CSTL stock price forecast at $52.00 and the lowest CSTL stock price forecast at $40.00.

On average, Wall Street analysts predict that Castle Biosciences's share price could reach $44.40 by May 13, 2027. The average Castle Biosciences stock price prediction forecasts a potential upside of 117.01% from the current CSTL share price of $20.46.

What is CSTL's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CSTL) Castle Biosciences's current Earnings Per Share (EPS) is -$0.42. On average, analysts forecast that CSTL's EPS will be -$1.48 for 2026, with the lowest EPS forecast at -$1.71, and the highest EPS forecast at -$1.09. On average, analysts forecast that CSTL's EPS will be -$0.84 for 2027, with the lowest EPS forecast at -$1.05, and the highest EPS forecast at -$0.39. In 2028, CSTL's EPS is forecast to hit -$0.51 (min: -$1.19, max: $0.09).

What is CSTL's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: CSTL) forecast ROE is 2.15%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.